Advertisement

The Heart Rhythm Society/American College of Physicians Atrial Fibrillation Screening and Education Initiative

      Background

      The prevalence of both atrial fibrillation (AF) and stroke is increasing. Stroke is common in AF and can have devastating consequences, especially when AF is unrecognized and anticoagulation is not initiated.

      Objective

      The purpose of this study was to demonstrate the feasibility and yield, both in identifying previously undiagnosed AF and in educating patients and caregivers about AF, of systematic screening events in internal medicine practices using a mobile electrocardiogram device (Kardia/AliveCor iECG).

      Methods

      With support from the Heart Rhythm Society and the American College of Physicians, 5 internal medicine practices performed systematic screening and education of patients at higher risk of AF using the Kardia/AliveCor device and a variety of educational materials. Patients screened as “unclassified” or “possible AF” were referred for further evaluation. Patients and providers (physicians, nurses, and allied professionals) assessed the screening process.

      Results

      A total of 772 patients were screened. The mean age was 65.2 ± 15.4 years, and 281 (28.2%) were 75 years or older. The majority, 521 (67.5%), were female, and 586 (75.7%) had a CHA2DS2-VASc score of ≥2. Six hundred seventy patients (86.8%) were screened as “normal,” 85 (11.0%) as “unclassified,” and 17 (2.2%) as “possible AF.” Participants demonstrated a significant knowledge deficit about stroke and AF before the screening events, and the majority felt that their awareness of these issues increased significantly as a result of their participation.

      Conclusion

      This collaborative Heart Rhythm Society/American College of Physicians systematic screening effort using the Kardia/AliveCor device was feasible. Although it resulted in a relatively modest yield of “unclassified” or “possible AF” screens, it had significant educational benefit to participants and caregivers. The diagnostic yield of future programs could be enriched by including more elderly patients and those with more risk factors for AF and stroke. A greater duration or frequency of monitoring would likely increase sensitivity but be more complicated and costlier to administer. Future events should include on-site confirmatory testing with a 12-lead electrocardiogram. Devices such as the Kardia/AliveCor monitor may enhance patient engagement in screening programs.

      Keywords

      To read this article in full you will need to make a payment
      Subscribe to Heart Rhythm
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Colilla S.
        • Crow A.
        • Petkun W.
        • Singer D.E.
        • Simon T.
        • Liu X.
        Estimates of current and future incidence and prevalence of atrial fibrillation in the US adult population.
        Am J Cardiol. 2013; 112: 1142-1147
        • Naccarelli G.V.
        • Varker H.
        • Lin J.
        • Schulman K.L.
        Increasing prevalence of atrial fibrillation and flutter in the United States.
        Am J Cardiol. 2009; 104: 1534-1539
        • Lloyd-Jones D.M.
        • Wang T.J.
        • Leip E.P.
        • et al.
        Lifetime risk for the development of atrial fibrillation: the Framingham Heart Study.
        Circulation. 2004; 110: 1042-1046
        • GBD 2016 Lifetime Risk of Stroke Collaborators
        • Feigin V.L.
        • Nguyen G.
        • Cercy K.
        • et al.
        Global, regional, and country-specific lifetime risks of stroke, 1990 and 2016.
        N Engl J Med. 2018; 379: 2429-2437
        • Wolf P.A.
        • Abbott R.D.
        • Kannel W.B.
        Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.
        Stroke. 1991; 22: 983-988
        • Go A.S.
        The epidemiology of atrial fibrillation in elderly persons: the tip of the iceberg.
        Am J Geriatr Cardiol. 2005; 14: 56-61
        • Lin H.J.
        • Wolf P.A.
        • Kelly-Hayes M.
        • et al.
        Stroke severity in atrial fibrillation.
        Stroke. 1996; 27: 1760-1764
        • Lamassa M.
        • Di Carlo A.
        • Pracucci G.
        • et al.
        Characteristics, outcome, and care of stroke associated with atrial fibrillation in Europe: data from a multicenter multinational hospital-based registry (The European Community Stroke Project).
        Stroke. 2001; 32: 392-398
        • Oldgren J.
        • Healey J.S.
        • Ezekowitz M.
        • et al.
        Variations in cause and management of atrial fibrillation in a prospective registry of 15400 emergency department patients in 46 countries.
        Circulation. 2014; 129: 1568-1576
        • Thijs V.
        Atrial fibrillation detection: fishing for an irregular heartbeat before and after stroke.
        Stroke. 2017; 48: 2671-2677
        • Fitzmaurice D.A.
        • Hobbs F.D.R.
        • Jowett S.
        • et al.
        Screening versus routine practice in detection of atrial fibrillation in patients age 65 or over: cluster randomized controlled trial.
        BMJ. 2007; 335: 383
        • Engdahl J.
        • Andersson L.
        • Mirskaya M.
        • Rosenqvist M.
        Stepwise screening of atrial fibrillation in a 75-year-old population: implications for stroke prevention.
        Circulation. 2013; 127: 930-937
        • Svennberg E.
        • Engdahl J.
        • Al-Khalili F.
        • Friberg L.
        • Frykman V.
        • Rosenqvist M.
        Mass screening for untreated atrial fibrillation: the STROKESTOP study.
        Circulation. 2015; 131: 2176-2184
        • Halcox J.P.J.
        • Wareham K.
        • Cardew A.
        • et al.
        Assessment of remote heart rhythm sampling using the AliveCor heart monitor to screen for atrial fibrillation: the REHEARSE-AF study.
        Circulation. 2017; 136: 1784-1794
        • Kirchhof P.
        • Benussi S.
        • Kotecha D.
        • et al.
        2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.
        Eur Heart J. 2016; 37: 2893-2962
        • January C.T.
        • Wann L.S.
        • Alpert J.S.
        • et al.
        2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.
        Circulation. 2014; 130: e199-e267
        • William A.D.
        • Kanbour M.
        • Callahan T.
        • et al.
        Assessing the accuracy of an automated atrial fibrillation detection algorithm using smartphone technology: the iREAD Study.
        Heart Rhythm. 2018; 15: 1561-1565
        • Bretthauer M.
        • Kaminski M.F.
        • Loberg M.
        • et al.
        Population-based colonoscopy screening for colorectal cancer: a randomized clinical trial.
        JAMA Intern Med. 2016; 176: 894-902
        • Jonas D.E.
        • Kahwati L.C.
        • Yun J.D.Y.
        • Middleton J.C.
        • Coker-Schwimmer M.
        • Asher G.N.
        Screening for atrial fibrillation with electrocardiography: evidence report and systematic review for the US Preventive Services Task Force.
        JAMA. 2018; 320: 485-498
        • Sanna T.
        • Diener H.-C.
        • Passman R.S.
        • Di Lazzaro V.
        • Bernstein R.A.
        • Morillo C.A.
        • Rymer M.M.
        • Thijs V.
        • Rogers T.
        • Beckers F.
        • Kindborg K.
        • Brachmann J.
        • et al.
        • for the CRYSTAL AF Investigators
        Cryptogenic stroke and underlying atrial fibrillation.
        N Engl J Med. 2014; 370: 2478-2486